Spots Global Cancer Trial Database for Gene and Protein Expression Profiles After Treatment of Actinic Keratoses
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Gene and Protein Expression Profiles After Treatment of Actinic Keratoses
Official Title: Gene and Protein Expression Profiles After Treatment of Actinic Keratoses
Study ID: NCT05740969
Conditions
Study Description
Brief Summary: The primary aim of this study is to investigate the effect of 5-fluorouracil, imiquimod, and melatonin for actinic keratosis on immunological gene, and protein expressions profiles. Secondarily, the aim is to assess the effect of the treatment on the histopathology of actinic keratoses.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Zealand University Hospital, Roskilde, Region Sjælland, Denmark
Contact Details
Name: Ismail A. Gögenur, MD, DMSc
Affiliation: Center For Surgical Science, Dept. of Surgery, Zealand University Hosptial
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
